Working to cure cancer

At Suman Paul Laboratory, we are focused on building new therapies for cancer treatment. Our team is working on identifying novel cancer targets and generating antibodies and cell therapies to exploit the cancer targets.

Learn More

Publications

Antibodies to treat T cell leukemias and lymphomas

Our latest publication detailing the development of bispecific antibodies that selectively kill T cell leukemias and lymphomas and do not harm the normal human T cells

Science Translational Medicine 2021

Antibody targeting cancers with p53 mutation

Mutations in p53 tumor suppression gene leads to cancer. We generated an antibody that specifically kills the cancer cells carrying the mutant p53 protein.

Science 2021

Antibodies targeting cancers with RAS mutations

Mutations in RAS oncogene lead to cancer. We generated an antibody that specifically kills the cancer cells carrying the mutant p53 protein.

Science Immunology 2021